logo
Sign in

ELAN Stock Price, Chart, Stats & News

Elanco Animal Health Incorporated
Save
12.34B
Market cap
Current P/E
18.94x
Forward P/E

ELAN chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
46.45%
Operating margin
5.34%
Pretax margin
-4.75%
Net margin
-4.92%
Effective tax rate
-3.57%
ROA
-1.74%
ROE
-3.51%
D/E
0.61x
Interest coverage ratio
0.95x

ELAN valuation

P/E
P/S
2.44x
P/B
1.75x
P/CF
20.51x
P/FCF
40.46x
P/OCF
20.51x
PEG
0.07x
EV multiple
11.10x

About

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations.

Similar securities

Based on sector and market capitalization

Report issue